Susan Hasty, Publisher
Table of Contents . . . June 3rd, 2010
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Genetics and Environmental Business Week | Other Publications
Biotechnology Business - Compandia Announces New Chairman
T-Cell Lymphoma - Eisai Oncology to Present New Research on Product Portfolio, Pipeline at ASCO Annual Meeting
Non-Small Cell Lung Cancer - Exelixis Reports Encouraging Interim Data From an Ongoing Phase 1b/2 Study of XL184 With or Without Erlotinib in Patients With Non-Small Lung Cancer to be Presented at ASCO
Fibrosis - FibroGen Reports Preclinical Data Showing that FG-3019 Reversed the Process of Fibrosis in the Lung
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.